Response of refractory osteosarcoma to thalidomide and celecoxib

Lancet Oncology

Volumn 6, Issue 12, 2005, Pages 997-999

  Tsai, Yu Chieh ^a   Wu, Chen Tu ^a   Hong, Ruey Long ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CISPLATIN; DOXORUBICIN; THALIDOMIDE;

ADULT; ARTHRALGIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; HIP ARTHROPLASTY; HUMAN; LUNG METASTASIS; LUNG RESECTION; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; SALVAGE THERAPY; THORAX RADIOGRAPHY;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; HIP; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OSTEOSARCOMA; PYRAZOLES; SULFONAMIDES; THALIDOMIDE; TREATMENT OUTCOME;

EID: 28044470068     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70468-X     Document Type: Article

References (9)

1. H Tsuchiya Y Kanazawa ME Abdel-Wanis et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: The Japanese Musculoskeletal Oncology Group study J Clin Oncol 20 20 3470-3477
2. JC Gentet M Brunat-Mentigny MC Demaille et al. Ifosfamide and etoposide in childhood osteosarcoma: A phase II study of the French Society of Paediatric Oncology Eur J Cancer 33 1997 232-237
3. DS Dickens R Kozielski J Khan et al. Cyclooxygenase-2 expression in pediatric sarcomas Pediatr Dev Pathol 5 2002 356-364
4. DS Dickens TP Cripe Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts J Pediatr Hematol Oncol 2003 25 709-714
5. CS Williams M Tsujii J Reese et al. Host cyclooxygenase-2 modulates carcinoma growth J Clin Invest 105 2000 1589-1594
6. X Liu P Yue Z Zhou et al. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells J Natl Cancer Inst 96 2004 1769-1780
7. ME Franks GR Macpherson WD Figg Thalidomide Lancet 363 2004 1802-1811
8. J Fujita JR Mestre JB Zeldis et al. Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2 Clin Cancer Res 7 2001 3349-3355
9. CS Chen D Hillebrand K Hill et al. A pilot study of celecoxib combined with escalating doses of thalidomide for treatment of unresectable hepatocellular carcinoma (HCC) Proc Am Soc Clin Oncol 21 2002 (abstr) 2350